Last 12 months
Inside the activity.
0 purchase rows · 457 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 47 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 41 |
| Feb 2026 | 0 | 21 |
| Mar 2026 | 0 | 54 |
| Apr 2026 | 0 | 29 |
| May 2026 | 0 | 33 |
| Jun 2026 | 0 | 68 |
| Jul 2026 | 0 | 47 |
| Aug 2026 | 0 | 33 |
| Sep 2026 | 0 | 59 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2025 Filed Feb 1, 2025 02:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 1,053 | $165.87 | $174,659.74 |
DisclosureSEC source: 0001415889-25-002626 · form4-01312025_090112.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,104 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:35 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 4 | $167.36 | $669.44 |
DisclosureSEC source: 0001415889-25-002625 · form4-01312025_090110.xml · nonDerivative · entry 2 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,383,177 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:35 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
SaleCommon Stock | 5,999 | $165.87 | $995,046.33 |
DisclosureSEC source: 0001415889-25-002625 · form4-01312025_090110.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,383,181 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 2 | $167.20 | $334.40 |
DisclosureSEC source: 0001415889-25-002624 · form4-01312025_090108.xml · nonDerivative · entry 3 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,020 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 3,730 | $165.87 | $618,690.25 |
DisclosureSEC source: 0001415889-25-002624 · form4-01312025_090108.xml · nonDerivative · entry 2 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,022 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 1,041 | $165.87 | $172,669.32 |
DisclosureSEC source: 0001415889-25-002624 · form4-01312025_090108.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,752 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023. Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,442 | $161.87 | $233,416.54 |
DisclosureSEC source: 0001415889-25-002325 · form4-01292025_090101.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,032 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
GiftCommon Stock | 588 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002326 · form4-01292025_090104.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,157 F1 · shares: Represents a charitable contribution by the Reporting Person. Read SEC document |
| January 24, 2025 Filed Jan 25, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 259 | $172.44 | $44,662.09 |
DisclosureSEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 4 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,474 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| January 24, 2025 Filed Jan 25, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 687 | $171.80 | $118,026.60 |
DisclosureSEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,733 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| January 23, 2025 Filed Jan 25, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 495 | $171.09 | $84,689.55 |
DisclosureSEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,420 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 194 | $171.97 | $33,362.01 |
DisclosureSEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 4 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,629 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.8937 to $172.0100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 78,359 | $164.95 | $12,925,223.02 |
DisclosureSEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 3 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,823 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 64 | $171.95 | $11,004.54 |
DisclosureSEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 4 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,665 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.90 to $171.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 25,867 | $164.95 | $4,266,730.61 |
DisclosureSEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,729 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 7 | $171.91 | $1,203.36 |
DisclosureSEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 4 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 261,745 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.90 to $171.9160 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 964 | $164.95 | $159,010.64 |
DisclosureSEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 261,752 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 54 | $171.95 | $9,285.19 |
DisclosureSEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 4 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,793 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.9347 to $171.9700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 02:45 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 21,985 | $164.95 | $3,626,399.37 |
DisclosureSEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 3 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,847 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:45 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 53 | $171.96 | $9,113.97 |
DisclosureSEC source: 0001415889-25-002081 · form4-01242025_090101.xml · nonDerivative · entry 2 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,230 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.9160 to $171.9700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:45 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 21,175 | $164.95 | $3,492,790.84 |
DisclosureSEC source: 0001415889-25-002081 · form4-01242025_090101.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,283 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:45 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 62 | $171.95 | $10,661.16 |
DisclosureSEC source: 0001415889-25-002082 · form4-01242025_090103.xml · nonDerivative · entry 2 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,684 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.90 to $171.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:45 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 24,799 | $164.95 | $4,090,565.29 |
DisclosureSEC source: 0001415889-25-002082 · form4-01242025_090103.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,746 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002083 · form4-01242025_090106.xml · derivative · entry 5 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001894 · form4-01222025_090104.xml · derivative · entry 6 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionCommon Stock | 1,775 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001893 · form4-01222025_090101.xml · derivative · entry 6 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,145 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 1,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
Exercise / conversionRestricted Stock Unit · Derivative | 144 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001896 · form4-01222025_090109.xml · derivative · entry 8 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter F6 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
Exercise / conversionCommon Stock | 144 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 644 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001895 · form4-01222025_090107.xml · derivative · entry 6 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 02:45 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 2 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 239,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001894 · form4-01222025_090104.xml · derivative · entry 5 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,544 Underlying: Common Stock · 3,386 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionCommon Stock | 3,386 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 344,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001893 · form4-01222025_090101.xml · derivative · entry 5 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,087 Underlying: Common Stock · 1,522 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 1,522 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
Exercise / conversionRestricted Stock Unit · Derivative | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001896 · form4-01222025_090109.xml · derivative · entry 7 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 761 Underlying: Common Stock · 191 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
Exercise / conversionCommon Stock | 191 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 856 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001895 · form4-01222025_090107.xml · derivative · entry 5 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,424 Underlying: Common Stock · 856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| January 20, 2025 Filed Jan 23, 2025 02:45 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 239,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
GrantCommon Stock | 10,822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001833 · form4-01212025_090105.xml · nonDerivative · entry 3 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,458 F4 · shares: On June 10, 2022, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 10,822 shares of Common Stock. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
GrantCommon Stock | 29,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001833 · form4-01212025_090105.xml · nonDerivative · entry 2 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,636 F3 · shares: On January 27, 2023, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 29,798 shares of Common Stock. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
GrantCommon Stock | 13,696 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001833 · form4-01212025_090105.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,838 F1 · shares: On January 28, 2022, the Reporting Person was granted a performance-based Restricted Stock Unit ("RSU") award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
GrantCommon Stock | 9,620 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001834 · form4-01212025_090108.xml · nonDerivative · entry 3 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,545 F4 · shares: On June 10, 2022, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 9,620 shares of Common Stock. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
GrantCommon Stock | 29,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001834 · form4-01212025_090108.xml · nonDerivative · entry 2 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,925 F3 · shares: On January 27, 2023, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 29,798 shares of Common Stock. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
GrantCommon Stock | 9,130 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001834 · form4-01212025_090108.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,127 F1 · shares: On January 28, 2022, the Reporting Person was granted a performance-based Restricted Stock Unit ("RSU") award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionRestricted Stock Unit · Derivative | 54,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001832 · form4-01212025_090103.xml · derivative · entry 3 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. F3 · derivative.exercise_date: On January 28, 2022, the Reporting Person was granted a performance-based RSU award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs. F3 · derivative.expiration_date: On January 28, 2022, the Reporting Person was granted a performance-based RSU award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
GrantCommon Stock | 101,812 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001832 · form4-01212025_090103.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,021 F2 · shares: On January 27, 2023, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 101,812 shares of Common Stock. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 02:45 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionCommon Stock | 54,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001832 · form4-01212025_090103.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.